Severstal Buys All Common Shares of Crew Gold

Nord Gold N.V. ("Nord Gold"), a subsidiary of OAO Severstal ("Severstal") (LSE:SVST)(RT:CHMF), announced today that it had acquired through a subsidiary all common shares ("Common Shares") of Crew Gold Corporation ("Crew Gold") that it did not already own at a price of US$4.65 (CAD$4.62) per Common Share pursuant to a plan of arrangement under the laws of the Yukon Territory.

A total of 7,077,313 Common Shares were acquired, which represent ownership and control of approximately 6.62% of the issued and outstanding Common Shares as at the date hereof.

Following this transaction Severstal will have ownership and control over 106,922,322 Common Shares, representing 100% of the issued and outstanding Common Shares as at the date hereof. The acquisition occurred under a statutory plan of arrangement which took effect as of January 7, 2011.

The additional acquisition of Common Shares was effected to complete Severstal's acquisition of Crew Gold. Severstal controlled Crew Gold prior to this purchase and will continue to control Crew Gold.

Severstal began the acquisition of Crew Gold shares at the beginning of 2010, after Crew Gold had undertaken a restructuring in response to financial difficulties. In June 2010, Severstal became a control shareholder and, after acquiring a 43.21% stake from Endeavour Financial Corporation, Severstal became a 93.38% shareholder. Today Severstal announces its full control over Crew Gold.

Nikolai Zelenski, CEO of Nord Gold commented:

"We are very pleased to fully integrate Crew Gold into our gold segment having assumed full control of its shares. This will enable us to continue and escalate ongoing investment into this asset, with a focus on improvements to its operational and financial efficiency. Crew Gold is a very significant part of our growing gold mining business and one which I believe will deliver real value to shareholders as well as make a contribution to the development of the local territory and Guinea as a whole."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.